165 related articles for article (PubMed ID: 35930252)
1. Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey.
Reddy A; Sinclair C; Crawford GB; McPherson ML; Mercadante S; Hui D; Haider A; Arthur J; Tanco K; Dalal S; Dev R; Amaram-Davila J; Adile C; Liu D; Schuler U; Jammi S; Shelal Z; Del Fabbro E; Davis M; Bruera E
J Palliat Med; 2022 Oct; 25(10):1557-1562. PubMed ID: 35930252
[No Abstract] [Full Text] [Related]
2. The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients.
Reddy A; Vidal M; Stephen S; Baumgartner K; Dost S; Nguyen A; Heung Y; Kwan S; Wong A; Pangemanan I; Azhar A; Tayjasanant S; Rodriguez E; Waletich J; Lim KH; Wu J; Liu D; Williams J; Yennurajalingam S; Bruera E
J Pain Symptom Manage; 2017 Sep; 54(3):280-288. PubMed ID: 28711751
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
4. Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.
Jackson LD; Wortzman R; Chua D; Selby D
J Oncol Pharm Pract; 2021 Jan; 27(1):238-243. PubMed ID: 32501183
[TBL] [Abstract][Full Text] [Related]
5. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians.
Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H
J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876
[TBL] [Abstract][Full Text] [Related]
6. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study.
Lawlor P; Turner K; Hanson J; Bruera E
Pain; 1997 Aug; 72(1-2):79-85. PubMed ID: 9272790
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Institutional Opioid Equianalgesia Tools: A National Study.
Wen RY; Atayee RS; Edmonds KP
J Palliat Med; 2022 Nov; 25(11):1686-1691. PubMed ID: 35559657
[No Abstract] [Full Text] [Related]
8. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Juba KM; Wahler RG; Daron SM
J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
[TBL] [Abstract][Full Text] [Related]
9. Pediatric palliative care: use of opioids for the management of pain.
Zernikow B; Michel E; Craig F; Anderson BJ
Paediatr Drugs; 2009; 11(2):129-51. PubMed ID: 19301934
[TBL] [Abstract][Full Text] [Related]
10. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E
Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687
[TBL] [Abstract][Full Text] [Related]
11. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain.
Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E
J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675
[TBL] [Abstract][Full Text] [Related]
12. Variability in Opioid Equivalence Calculations.
Rennick A; Atkinson T; Cimino NM; Strassels SA; McPherson ML; Fudin J
Pain Med; 2016 May; 17(5):892-898. PubMed ID: 26352991
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
14. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
15. Resolution of Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid Rotation to Fentanyl: A Case Series.
Veizi E; Tornero-Bold M; Hayek SM
Pain Pract; 2016 Jul; 16(6):E94-8. PubMed ID: 26990069
[TBL] [Abstract][Full Text] [Related]
16. Conversion of Intrathecal Opioids to Fentanyl in Chronic Pain Patients With Implantable Pain Pumps: A Retrospective Study.
Kim DD; Patel A; Sibai N
Neuromodulation; 2019 Oct; 22(7):823-827. PubMed ID: 30840355
[TBL] [Abstract][Full Text] [Related]
17. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
[TBL] [Abstract][Full Text] [Related]
18. Opioid conversion ratios used in palliative care: is there an Australian consensus?
Syrmis W; Good P; Wootton J; Spurling G
Intern Med J; 2014 May; 44(5):483-9. PubMed ID: 24589128
[TBL] [Abstract][Full Text] [Related]
19. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
[TBL] [Abstract][Full Text] [Related]
20. Conversion From Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit.
Harkin M; Miller JL; Lim SY; Neely SB; Walsh CK; Johnson PN
Ann Pharmacother; 2021 Dec; 55(12):1439-1446. PubMed ID: 33745290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]